Bourlón CRA, Pérez PI, Bourlón RC, Mora ATT, Carrillo MR

Language: Spanish
References: 23
Page: 603-608
PDF size: 283.03 Kb.

ABSTRACT

Neurocysticercosis is a disease that even nowadays is of high prevalence, the clinical and imagenological diagnosis present a challenge to the clinician regardless of the great advances in the laboratory and imaging fields. neurocysticercosis is a cause of research and neuroimaging has been able to explain its evolution to a certain extent. Reports have been made related to immunologic interactions between the host and the parasite, and the most significant, the controversy of the relation of neurocysticercosis with tumoral processes. We present a case that received the initial diagnosis of lymphoma in which afterwards, according to short term imagenologic evolution and response to treatment, the diagnosis of neurocysticercosis was confirmed.

REFERENCES

1. Del Brutto OH, Santibañez R, Noboa CA, Aguirre R, et al. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992;42(2):389-392.

2. Sinha S, Sharma BS. Neurocysticercosis: A review of current status and management. J Clin Neurosci 2009;16(7):867-876.

3. Carpio A. Neurocysticercosis: an update. Lancet Infect Dis 2002;2(12):751-762.

4. Schenone H, Villarroel F, Rojas A, Ramírez R. Epidemiology of human cysticercosis in Latin America. Cysticercosis. En: Wilms K, ed. Cysticercosis. Present state of knowledge and perspectives. New York: Academic Press, 1982;25-38.

5. Velasco-Suárez M, Bravo MA, Quirasco F. Human cysticercosis: Medical-social implications and economic impact. In: Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, Beltrán F, ed. Cysticercosis. Present state of knowledge and perspectives. New York: Academic Press, 1982;47-51.

6. Diaz Camacho S, Candil Ruiz A, Uribe Beltrán M, Willms K. Serology as an indicator of Taenia solium tapeworm infections in a rural community in Mexico. Trans Royal Soc Trop Med Hyg 1990;84(4):563-566.

7. Grogl M, Estrada JJ, MacDonald G, Kuhn RE. Antigen-antibody analyses in neurocysticercosis. J Parasitol 1985;71(4):433-442.

8. Zini D, Farrell VJR, Wadee AA. The relationship of antibody levels to the clinical spectrum of human neurocysticercosis. J Neurol Neurosurg Psychiatry 1990;53(8):656-661.

9. Cho SY, Kim SI, Kang SY, Park AJ. Intracranial synthesis of specific IgG antibody in cerebrospinal fluid of neurocysticercosis patients. Kisaengchunghak Chapchi 1988;26(1):15-26.

10. Ostrosky-Zeichner L, Estanol B. Immunopathogenesis of neurocysticercosis: is damage mediated by the host immune response? Int J Parasitol. 1999;29(4):649-650.

11. Hautecoeur P, Gallois P, Brucher JM, Ovelacq E, Dereux JF. Association d’une cysticercose cerebrale et d’un gliome multifocal discussion des interactions. Rev Neurol (Paris). 1987;143(12):844-849.

12. Agapejev S, Alves A, Zanini MA, Ueda AK, Pereira EM. Oligodendroglioma cistico e positivadade das reacoes para cisticercose: relato de caso. Arq Neuropsiquiatr 1992;50(2):234-238.

13. Del Brutto OH, Castillo PR, Mena IX, et al. Neurocysticercosis among patients with cerebral gliomas. Arch Neurol 1997;54(9):1125-1128.

14. Montero R, Flisser A, Madrazo I, Cuevas C, Ostrosky-Wegman P. Mutation at the HPRT locus in patients with neurocysticercosis treated with praziquantel. Mutat Res 1994;305(2):181-188.

15. Flisser A, Gonzalez D, Plancarte A, Ostrosky P, et al. Praziquantel treatment of brain and muscle porcine Taenia solium cysticercosis. 2. Immunological and cytogenetic studies. Parasitol Res 1990;76(7):640-642.

16. Richards F, Schantz PM. Laboratory diagnosis of cisticercosis. Clin Lab Med 1991;11(4):1011-1028.

17. García HH, Del Brutto OH. Taenia sollium Cisticercosis. Infect Dis Clin North Am 2000;14:97-119.

18. Amaral L, Maschietto M, Maschietto R, et al. Unusual manifestations of neurocysticercosis in MR imaging: analysis of 172 cases. Arq Neuropsiquiatr 2003;61:533-541.

19. Litt AW, Mohuchyt T. Case 10: neurocysticercosis. Radiology 1999;211(2):472-476.

20. Sheth TN, Pillon L, Keystone J, Kucharczyk W. Persistent MR contrast enhancement of calcified neurocysticercosis lesions. AJNR Am J Neuroradiol 1998;19(1):79-82.

21. Creasy JL, Alarcon JJ. Magnetic resonance imaging of neurocysticercosis. Top Magn Reson Imaging 1994;6(1):59-68.

22. Del Brutto OH, Rajshekhar V, White AC, Tsang VC, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57(2):177-183.

23. García HH, Evans CA, Nash TE, Takayanagui OM, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002;15(4):747-756.